LT Wire
Sep 09, 2026

AlzeCure CEO to present Alzheimer’s progress, Eli Lilly partnership in Stockholm

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

AlzeCure Pharma will present at Aktiedagen in Stockholm on 15 September.

CEO Martin Jönsson will deliver a corporate presentation and provide an update on the company’s recently announced out-licensing agreement with Eli Lilly and a collaboration with QuantumCell relating to AlzeCure’s Alzheimer’s disease projects.

The presentation is scheduled for 16:25 CEST at Birger Jarl Konferens, Birger Jarlsgatan 61 A in Stockholm and will be broadcast live and posted to the company’s website afterwards.

AlzeCure develops small-molecule drug candidates for central nervous system disorders and is advancing programs across its Alzstatin and NeuroRestore platforms. The firm is listed on Nasdaq First North Premier Growth Market.

Source: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/alzecure-pharma-to-present-at-aktiedagen-in-stockholm-on-september-15-1217990

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Alzheimer’s drug market faces a $14.7bn future

AlzeCure CEO to present Alzheimer’s progress, Eli Lilly partnership in Stockholm

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

You might also like

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Variant Bio extends AI genetics deal to the heart

Sava raises $36m as glucose sensor deal takes shape

The regulatory door is ajar

Perplexity enters the consumer health AI arena

Startup targets ‘untreatable blindness’ with bionic eye system

Science Corp lands $230m to commercialize vision restoration chip

Ergothioneine: The little-known molecule transforming brain health and longevity

COGNITION: FLT’s new brain-boosting supplement that’s redefining mental performance

7 Best l-glutamine supplements to buy in 2024

Abu Dhabi puts biological age to the test

Macau team uses TCM to crack XPRIZE’s top 10

EU longevity strategy gains political momentum

AlzeCure CEO to present Alzheimer’s progress, Eli Lilly partnership in Stockholm

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

You might also like

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE